Abstract

Soft-tissue sarcomas (STS) are a rare subtype of soft-tissue mass and are frequently misinterpreted as benign lesions. Magnetic resonance imaging (MRI) is the primary recommended type of diagnostics. To assess the quality of primary radiology reports, we investigated whether recommended MRI report elements were included in compliance with European Society of Musculoskeletal Radiology (ESSR) guidelines. A total of 1107 patients were evaluated retrospectively, and 126 radiological reports on patients with malignant STS were assessed for ESSR quality criteria. One or more required sequences or planes were missing in 67% of the reports. In all 126 cases, the report recognized the mass as anomalous (100%). Sixty-eight percent of the reports mentioned signs of malignancy. The majority of reports (n = 109, 87%) articulated a suspected diagnosis, 32 of which showed a mismatch with the final diagnosis (25%). Thirty-two percent of the reports had a misinterpretation of the masses as benign. Benign misinterpretations were more common in masses smaller than 5 cm (65% vs. 27%). Thirty percent of the reports suggested tissue biopsy and 6% recommended referral to a sarcoma center. MRI reports showed frequent deviations from ESSR guidelines, and protocol guidelines were not routinely met. Deviations from standard protocol and reporting guidelines could put patients at risk for inadequate therapy.

Highlights

  • Soft tissue sarcomas (STS) are a rare subtype of soft-tissue mass, representing less than 1% of all malignancies [1]

  • Sensitivity of detecting soft-tissue sarcoma out of all soft-tissue masses through magnetic resonance imaging (MRI) imaging has been described at only 80% in prospective studies [6]

  • Frequently not included in initial MRI reports of soft-tissue sarcomas. To their rare incidence, physicians, including primary-care physicians, Due Due to their rare incidence, many many physicians, including primary-care physicians, ororthopedic, plasticor general surgeons, and radiologists that practice outside specialized thopedic, plastic- or general surgeons, and radiologists that practice outside specialized sarcoma centers are only infrequently confronted soft-tissue sarcomas

Read more

Summary

Introduction

Soft tissue sarcomas (STS) are a rare subtype of soft-tissue mass, representing less than 1% of all malignancies [1]. The incidence in Europe is estimated at 3.6–4.7 cases per. 100,000 people every year [2,3,4]. Due to their rareness, soft-tissue sarcomas are frequently mistaken for benign soft-tissue lesions, which are 300 times more common [5]. Sensitivity of detecting soft-tissue sarcoma out of all soft-tissue masses through MRI imaging has been described at only 80% in prospective studies [6]. Misdiagnosis leads to unplanned excisions and, to inadequate therapy.

Objectives
Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call